WNT5B, Wnt family member 5B, 81029

N. diseases: 39; N. variants: 6
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0023267
Disease: Fibroid Tumor
Fibroid Tumor
0.310 AlteredExpression disease BEFREE Treatment with 9-cis retinoic acid significantly inhibited Wnt5b expression in myometrial SMC but not in their leiomyoma counterparts. 15972578 2005
CUI: C0023267
Disease: Fibroid Tumor
Fibroid Tumor
0.310 Biomarker disease CTD_human Treatment with 9-cis retinoic acid significantly inhibited Wnt5b expression in myometrial SMC but not in their leiomyoma counterparts. 15972578 2005
CUI: C0023267
Disease: Fibroid Tumor
Fibroid Tumor
0.310 AlteredExpression disease LHGDN Treatment with 9-cis retinoic acid significantly inhibited Wnt5b expression in myometrial SMC but not in their leiomyoma counterparts. 15972578 2005
CUI: C0042133
Disease: Uterine Fibroids
Uterine Fibroids
0.310 AlteredExpression group BEFREE Treatment with 9-cis retinoic acid significantly inhibited Wnt5b expression in myometrial SMC but not in their leiomyoma counterparts. 15972578 2005
CUI: C0042133
Disease: Uterine Fibroids
Uterine Fibroids
0.310 Biomarker group CTD_human Treatment with 9-cis retinoic acid significantly inhibited Wnt5b expression in myometrial SMC but not in their leiomyoma counterparts. 15972578 2005
CUI: C0010606
Disease: Adenoid Cystic Carcinoma
Adenoid Cystic Carcinoma
0.300 Biomarker disease CTD_human Genes associated with early development, apoptosis and cell cycle regulation define a gene expression profile of adenoid cystic carcinoma. 16762588 2006
CUI: C0036095
Disease: Salivary Gland Neoplasms
Salivary Gland Neoplasms
0.300 Biomarker group CTD_human Genes associated with early development, apoptosis and cell cycle regulation define a gene expression profile of adenoid cystic carcinoma. 16762588 2006
Malignant neoplasm of salivary gland
0.300 Biomarker disease CTD_human Genes associated with early development, apoptosis and cell cycle regulation define a gene expression profile of adenoid cystic carcinoma. 16762588 2006
CUI: C0005938
Disease: Bone Density
Bone Density
0.100 GeneticVariation phenotype GWASCAT Life-Course Genome-wide Association Study Meta-analysis of Total Body BMD and Assessment of Age-Specific Effects. 29304378 2018
CUI: C0003868
Disease: Arthritis, Gouty
Arthritis, Gouty
0.100 GeneticVariation disease GWASCAT Gout and type 2 diabetes have a mutual inter-dependent effect on genetic risk factors and higher incidences. 22179738 2012
CUI: C0018099
Disease: Gout
Gout
0.100 GeneticVariation disease GWASCAT Gout and type 2 diabetes have a mutual inter-dependent effect on genetic risk factors and higher incidences. 22179738 2012
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.030 Biomarker group BEFREE Limited investigations revealed a possible role of WNT5B in malignancies, such as triple-negative breast cancer and oral squamous cell carcinoma. 31666682 2020
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.030 Biomarker disease BEFREE Limited investigations revealed a possible role of WNT5B in malignancies, such as triple-negative breast cancer and oral squamous cell carcinoma. 31666682 2020
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.030 Biomarker group BEFREE These results suggest that Wnt5b-associated exosomes promote cancer cell migration and proliferation in a paracrine manner. 27762090 2017
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.030 AlteredExpression disease BEFREE Interestingly, the high level of WNT5B protein in serum was associated with lymph node metastasis in OSCC patients. 27593938 2017
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.030 Biomarker group BEFREE WNT5B is a member of the WNT family that has been reported to be overexpressed in a variety of cancer cell lines and tissues, including colorectal cancer (CRC). 27121420 2016
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.030 Biomarker disease BEFREE Wnt5b promotes the cell motility essential for metastasis of oral squamous cell carcinoma through active Cdc42 and RhoA. 24220306 2014
Diabetes Mellitus, Non-Insulin-Dependent
0.030 AlteredExpression disease BEFREE Down-regulation of Wnt5b could therefore contribute to decreased adipogenesis observed in T2DM diabetic subjects. 19577541 2009
Diabetes Mellitus, Non-Insulin-Dependent
0.030 GeneticVariation disease BEFREE Two thousand seven hundred and one Caucasian middle-aged men from the prospective Northwick Park Heart Study II (NPHSII) of whom 153 developed T2D over 15 years and 1268 Caucasian middle-aged patients with T2D (60% male) were genotyped using a TaqMan assay for the IVS3C>G variant (rs2270031) in the WNT5B gene. 18555673 2009
Diabetes Mellitus, Non-Insulin-Dependent
0.030 GeneticVariation disease BEFREE As a result, one SNP locus in the WNT5B gene was strongly associated with type 2 diabetes ( chi 2=15.6; P=.00008; odds ratio=1.74; 95% confidence interval 1.32-2.29). 15386214 2004
Secondary malignant neoplasm of lymph node
0.020 AlteredExpression disease BEFREE Here, we initially determine that WNT5B is highly expressed in LAD and is positively correlated with lymph node metastasis and TNM stage. 31666682 2020
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.020 AlteredExpression disease BEFREE IMP3 Stabilization of WNT5B mRNA Facilitates TAZ Activation in Breast Cancer. 29847788 2018
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.020 AlteredExpression disease BEFREE IMP3 Stabilization of WNT5B mRNA Facilitates TAZ Activation in Breast Cancer. 29847788 2018
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.020 AlteredExpression group BEFREE Knockdown of WNT5B expression in OSCC sublines did not affect tumour growth but impaired lymph node metastasis and tumour lymphangiogenesis of orthotopic transplantation. 27593938 2017
Secondary malignant neoplasm of lymph node
0.020 AlteredExpression disease BEFREE Knockdown of WNT5B expression in OSCC sublines did not affect tumour growth but impaired lymph node metastasis and tumour lymphangiogenesis of orthotopic transplantation. 27593938 2017